Grown Rogue International (GRUSF) Cash & Equivalents Growth (5y) (2014 - 2023)
Grown Rogue International (GRUSF) Cash & Equivalents Growth (5y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | 51.20% |
| Apr 30, 2023 | 50.11% |
| Oct 31, 2022 | -92.34% |
| Aug 31, 2018 | -34.97% |
| May 31, 2018 | 565.49% |
| Feb 28, 2018 | -51.22% |
| Nov 30, 2017 | -66.55% |
| Aug 31, 2017 | -69.54% |
| May 31, 2017 | -64.15% |
| Feb 28, 2017 | 86.09% |
| Nov 30, 2016 | -77.65% |
| Aug 31, 2016 | 23.48% |
| May 31, 2016 | -0.77% |
| Feb 29, 2016 | -22.48% |
| Nov 30, 2015 | 230.52% |
| Aug 31, 2015 | -9.73% |
| May 31, 2015 | -37.63% |
| Feb 28, 2015 | -24.31% |
| Nov 30, 2014 | -45.89% |
| Aug 31, 2014 | -9.31% |